Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 2/2019

27.09.2018 | Original Article

A Comparison of Pathologic Outcomes of Open, Laparoscopic, and Robotic Resections for Rectal Cancer Using the ACS-NSQIP Proctectomy-Targeted Database: a Propensity Score Analysis

verfasst von: Richard Garfinkle, Maria Abou-Khalil, Sahir Bhatnagar, Nathalie Wong-Chong, Laurent Azoulay, Nancy Morin, Carol-Ann Vasilevsky, Marylise Boutros

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

There is ongoing debate regarding the benefits of minimally invasive techniques for rectal cancer surgery. The aim of this study was to compare pathologic outcomes of patients who underwent rectal cancer resection by open surgery, laparoscopy, and robotic surgery using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) proctectomy-targeted database.

Methods

All patients from the 2016 ACS-NSQIP proctectomy-targeted database who underwent elective proctectomy for rectal cancer were identified. Patients were divided into three groups based on initial operative approach: open surgery, laparoscopy, and robotic surgery. Pathologic and 30-day clinical outcomes were then compared between the groups. A propensity score analysis was performed to control for confounders, and adjusted odds ratios for pathologic outcomes were reported.

Results

A total of 578 patients were included—211 (36.5%) in the open group, 213 (36.9%) in the laparoscopic group, and 154 (26.6%) in the robotic group. Conversion to open surgery was more common among laparoscopic cases compared to robotic cases (15.0% vs. 6.5%, respectively; p = 0.011). Positive circumferential resection margin (CRM) was observed in 4.7%, 3.8%, and 5.2% (p = 0.79) of open, laparoscopic, and robotic resections, respectively. Propensity score adjusted odds ratios for positive CRM (open surgery as a reference group) were 0.70 (0.26–1.85, p = 0.47) for laparoscopy and 1.03 (0.39–2.70, p = 0.96) for robotic surgery.

Conclusions

The use of minimally invasive surgical techniques for rectal cancer surgery does not appear to confer worse pathologic outcomes.
Literatur
1.
Zurück zum Zitat Heald RJ (1988). The holy plane of rectal surgery. J R Soc Med 81:503.CrossRef Heald RJ (1988). The holy plane of rectal surgery. J R Soc Med 81:503.CrossRef
2.
Zurück zum Zitat Kusters M, Marijnen CA, van de Velde CJ, et al (2010). Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 36:470–476.CrossRef Kusters M, Marijnen CA, van de Velde CJ, et al (2010). Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 36:470–476.CrossRef
3.
Zurück zum Zitat Parfitt JR, Driman DK (2007). The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol 60:849–855.CrossRef Parfitt JR, Driman DK (2007). The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol 60:849–855.CrossRef
4.
Zurück zum Zitat Nagtegaal ID, Quirke P (2008). What is the role for the circumferential margin in the modern treatment of rectal cancer?. J Clin Oncol 26:303–312.CrossRef Nagtegaal ID, Quirke P (2008). What is the role for the circumferential margin in the modern treatment of rectal cancer?. J Clin Oncol 26:303–312.CrossRef
5.
Zurück zum Zitat Simunovic M, Baxter NN, Sutradhar R, et al (2013). Uptake and patient outcomes of laparoscopic colon and rectal cancer surgery in a publicly funded system and following financial incentives. Ann Surg Oncol 20:3740–3746.CrossRef Simunovic M, Baxter NN, Sutradhar R, et al (2013). Uptake and patient outcomes of laparoscopic colon and rectal cancer surgery in a publicly funded system and following financial incentives. Ann Surg Oncol 20:3740–3746.CrossRef
6.
Zurück zum Zitat Schootman M, Hendren S, Ratnapradipa K, et al (2016). Adoption of robotic technology for treating colorectal cancer. Dis Colon rectum 59:1011–1018. Schootman M, Hendren S, Ratnapradipa K, et al (2016). Adoption of robotic technology for treating colorectal cancer. Dis Colon rectum 59:1011–1018.
7.
Zurück zum Zitat Carmichael JC, Masoomi H, Mills S, et al (2011). Utilization of laparoscopy in colorectal surgery for cancer at academic medical centers: does site of surgery affect rate of laparoscopy?. Am Surg 77:1300–1304.PubMed Carmichael JC, Masoomi H, Mills S, et al (2011). Utilization of laparoscopy in colorectal surgery for cancer at academic medical centers: does site of surgery affect rate of laparoscopy?. Am Surg 77:1300–1304.PubMed
8.
Zurück zum Zitat van der Pas MH, Haglind E, Cuesta MA, et al (2013). COLOR II Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14:210–218.CrossRef van der Pas MH, Haglind E, Cuesta MA, et al (2013). COLOR II Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14:210–218.CrossRef
9.
Zurück zum Zitat Kang SB, Park JW, Jeong SY, et al (2010). Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 11:637–645. Kang SB, Park JW, Jeong SY, et al (2010). Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 11:637–645.
10.
Zurück zum Zitat Stevenson AR, Solomon MJ, Lumley JW, et al (2015). ALaCaRT Investigators. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314:1356–1363.PubMed Stevenson AR, Solomon MJ, Lumley JW, et al (2015). ALaCaRT Investigators. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314:1356–1363.PubMed
11.
Zurück zum Zitat Fleshman J, Branda M, Sargent DJ, et al (2015). Effect of laparoscopic-assisted resection vs open resection in stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314:1346–1355.CrossRef Fleshman J, Branda M, Sargent DJ, et al (2015). Effect of laparoscopic-assisted resection vs open resection in stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314:1346–1355.CrossRef
12.
Zurück zum Zitat Spinelli A, D’Hoore A, Panis Y, et al (2017). Critical appraisal of two randomized clinical trials on pathologic outcomes: laparoscopic vs. open resection for rectal cancer. Coloproctol 39:277.CrossRef Spinelli A, D’Hoore A, Panis Y, et al (2017). Critical appraisal of two randomized clinical trials on pathologic outcomes: laparoscopic vs. open resection for rectal cancer. Coloproctol 39:277.CrossRef
13.
Zurück zum Zitat Hellan M, Ouellette J, Lagares-Garcia JA, et al (2015). Robotic rectal cancer resection: a retrospective multicenter analysis. Ann Surg Oncol 22:2151–2158.CrossRef Hellan M, Ouellette J, Lagares-Garcia JA, et al (2015). Robotic rectal cancer resection: a retrospective multicenter analysis. Ann Surg Oncol 22:2151–2158.CrossRef
14.
Zurück zum Zitat Sammour T, Malakorn S, Bednarski BK, et al (2016). Oncologic outcomes after robotic proctectomy for rectal cancer: analysis of a prospective database. Ann Surg Dec16; [Epub ahead of print]. Accessed on Nov 27, 2017. Sammour T, Malakorn S, Bednarski BK, et al (2016). Oncologic outcomes after robotic proctectomy for rectal cancer: analysis of a prospective database. Ann Surg Dec16; [Epub ahead of print]. Accessed on Nov 27, 2017.
15.
Zurück zum Zitat Jayne D, Pigazzi A, Marshall H, et al (2017). Effect of robotic-assisted vs. conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 318:1569–1580.CrossRef Jayne D, Pigazzi A, Marshall H, et al (2017). Effect of robotic-assisted vs. conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 318:1569–1580.CrossRef
16.
Zurück zum Zitat SilvaVelazco J, Dietz DW, Stocchi L, et al (2017). Considering value in rectal cancer surgery: an analysis of costs and outcomes based on the open, laparoscopic, and robotic approach for proctectomy. Ann Surg 265:960–968.CrossRef SilvaVelazco J, Dietz DW, Stocchi L, et al (2017). Considering value in rectal cancer surgery: an analysis of costs and outcomes based on the open, laparoscopic, and robotic approach for proctectomy. Ann Surg 265:960–968.CrossRef
17.
Zurück zum Zitat Baek SJ, Kim SH, Cho JS, et al (2012). Robotic versus conventional laparoscopic surgery for rectal cancer: a cost analysis from a single institute in Korea. World J Surg 36:2722–2729.CrossRef Baek SJ, Kim SH, Cho JS, et al (2012). Robotic versus conventional laparoscopic surgery for rectal cancer: a cost analysis from a single institute in Korea. World J Surg 36:2722–2729.CrossRef
18.
Zurück zum Zitat Hottenrott C (2011). Robotic versus laparoscopic surgery for rectal cancer and cost-effectiveness analysis. Surg Endosc 25:3954–3956.CrossRef Hottenrott C (2011). Robotic versus laparoscopic surgery for rectal cancer and cost-effectiveness analysis. Surg Endosc 25:3954–3956.CrossRef
19.
Zurück zum Zitat Al-Khamis A, Abou Khalil J, Demian M, et al (2016). Sigmoid colectomy for acute diverticulitis in immunosuppressed vs. immunocompetent patients: outcomes from the ACS-NSQIP database. Dis Colon rectum 59:101–109. Al-Khamis A, Abou Khalil J, Demian M, et al (2016). Sigmoid colectomy for acute diverticulitis in immunosuppressed vs. immunocompetent patients: outcomes from the ACS-NSQIP database. Dis Colon rectum 59:101–109.
20.
Zurück zum Zitat Cepeda MS, Boston R, Farrar JT, et al (2003). Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158:280–287.CrossRef Cepeda MS, Boston R, Farrar JT, et al (2003). Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158:280–287.CrossRef
22.
Zurück zum Zitat McCaffrey DF, Griffin BA, Almirali D, et al (2013). A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med 32:3388–3414.CrossRef McCaffrey DF, Griffin BA, Almirali D, et al (2013). A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med 32:3388–3414.CrossRef
23.
Zurück zum Zitat Meyerhardt JA, Tepper JE, Niedzwiecki D, et al (2004). Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 22:648–657.CrossRef Meyerhardt JA, Tepper JE, Niedzwiecki D, et al (2004). Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 22:648–657.CrossRef
24.
Zurück zum Zitat You JF, Tang R, Changchien CR, et al (2009). Effect of body mass index on the outcome of patients with rectal cancer receiving curative anterior resection: disparity between the upper and lower rectum. Ann Surg 249:783–787. You JF, Tang R, Changchien CR, et al (2009). Effect of body mass index on the outcome of patients with rectal cancer receiving curative anterior resection: disparity between the upper and lower rectum. Ann Surg 249:783–787.
25.
Zurück zum Zitat Chern H, Chou J, Donkor C, et al (2010). Effects of obesity in rectal cancer surgery. J Am Coll Surg 211:55–60.CrossRef Chern H, Chou J, Donkor C, et al (2010). Effects of obesity in rectal cancer surgery. J Am Coll Surg 211:55–60.CrossRef
26.
Zurück zum Zitat Thorpe H, Jayne DG, Guillou PJ, et al (2008). MRC-CLASICC Trial Group. Patient factors influencing conversion from laparoscopically assisted to open surgery for colorectal cancer. Br J Surg 95:199–205.CrossRef Thorpe H, Jayne DG, Guillou PJ, et al (2008). MRC-CLASICC Trial Group. Patient factors influencing conversion from laparoscopically assisted to open surgery for colorectal cancer. Br J Surg 95:199–205.CrossRef
27.
Zurück zum Zitat Qiu Y, Liu Q, Chen G, et al (2016). Outcome of rectal cancer surgery in obese and nonobese patients: a meta-analysis. World J Surg Oncol 14:23.CrossRef Qiu Y, Liu Q, Chen G, et al (2016). Outcome of rectal cancer surgery in obese and nonobese patients: a meta-analysis. World J Surg Oncol 14:23.CrossRef
28.
Zurück zum Zitat Allaix ME, Furnee EJB, Mistrangelo M, et al (2016). Conversion of laparoscopic colorectal resection for cancer: what is the impact on short-term outcomes and survival?. World J Gastroenterol 22:8304:8313.CrossRef Allaix ME, Furnee EJB, Mistrangelo M, et al (2016). Conversion of laparoscopic colorectal resection for cancer: what is the impact on short-term outcomes and survival?. World J Gastroenterol 22:8304:8313.CrossRef
29.
Zurück zum Zitat Freemantle N, Calvert M, Wood J, et al (2003). Composite outcomes in randomized trials: greater precision but with greater uncertainty?. JAMA 289:2554–2559. Freemantle N, Calvert M, Wood J, et al (2003). Composite outcomes in randomized trials: greater precision but with greater uncertainty?. JAMA 289:2554–2559.
30.
Zurück zum Zitat Taylor FG, Quirke P, Heald RJ, et al (2011); MERCURY Study Group. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253:711–719.CrossRef Taylor FG, Quirke P, Heald RJ, et al (2011); MERCURY Study Group. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253:711–719.CrossRef
31.
Zurück zum Zitat Mak TW, Lee JF, Futaba K, et al (2014). Robotic surgery for rectal cancer: a systematic review of current practice. World J Gastroenterol Oncol 6:184–193.CrossRef Mak TW, Lee JF, Futaba K, et al (2014). Robotic surgery for rectal cancer: a systematic review of current practice. World J Gastroenterol Oncol 6:184–193.CrossRef
32.
Zurück zum Zitat Sujatha-Bhaskar S, Jafari MD, Gahagan JV, et al (2017). Defining the role of minimally invasive proctectomy for locally advanced rectal adenocarcinoma. Ann Surg 266:574–581.CrossRef Sujatha-Bhaskar S, Jafari MD, Gahagan JV, et al (2017). Defining the role of minimally invasive proctectomy for locally advanced rectal adenocarcinoma. Ann Surg 266:574–581.CrossRef
33.
Zurück zum Zitat Prete FP, Pezzolla A, Prete F, et al (2017). Robotic versus laparoscopic minimally invasive surgery for rectal cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Surg Oct 3; [Epub ahead of print]. Accessed on Nov 27, 2017. Prete FP, Pezzolla A, Prete F, et al (2017). Robotic versus laparoscopic minimally invasive surgery for rectal cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Surg Oct 3; [Epub ahead of print]. Accessed on Nov 27, 2017.
34.
Zurück zum Zitat Moghadamyeghaneh Z, Phelan M, Smith BR, et al (2015). Outcomes of open, laparoscopic, and robotic abdominoperineal resections in patients with rectal cancer. Dis Colon rectum 58:1123–1129. Moghadamyeghaneh Z, Phelan M, Smith BR, et al (2015). Outcomes of open, laparoscopic, and robotic abdominoperineal resections in patients with rectal cancer. Dis Colon rectum 58:1123–1129.
35.
Zurück zum Zitat Sun Z, Kim J, Adam MA, et al (2016). Minimally invasive versus open low anterior resection: equivalent survival in a national analysis of 14,033 patients with rectal cancer. Ann Surg 263:1152–1158.CrossRef Sun Z, Kim J, Adam MA, et al (2016). Minimally invasive versus open low anterior resection: equivalent survival in a national analysis of 14,033 patients with rectal cancer. Ann Surg 263:1152–1158.CrossRef
36.
Zurück zum Zitat Khreiss W, Huebner M, Cima RR, et al (2014). Improving conventional recovery with enhanced recovery in minimally invasive surgery for rectal cancer. Dis Colon rectum 57:557–563. Khreiss W, Huebner M, Cima RR, et al (2014). Improving conventional recovery with enhanced recovery in minimally invasive surgery for rectal cancer. Dis Colon rectum 57:557–563.
37.
Zurück zum Zitat Vignali A, Elmore U, Cossu A, et al (2016). Enhanced recovery after surgery (ERAS) pathway vs. traditional care in laparoscopic recta resection: a single-center experience. Tech Coloproctol 20:559–566.CrossRef Vignali A, Elmore U, Cossu A, et al (2016). Enhanced recovery after surgery (ERAS) pathway vs. traditional care in laparoscopic recta resection: a single-center experience. Tech Coloproctol 20:559–566.CrossRef
38.
Zurück zum Zitat Huo YR, Phan K, Morris DL, et al (2017). Systematic review and meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery. J Gastrointest Oncol 8:534–546.CrossRef Huo YR, Phan K, Morris DL, et al (2017). Systematic review and meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery. J Gastrointest Oncol 8:534–546.CrossRef
39.
Zurück zum Zitat Leonard D, Penninckx F, Kartheuser A, et al (2014). PROCARE. Effect of hospital volume on quality of care and outcome after rectal cancer surgery. Br J Surg 101:1475–1482. Leonard D, Penninckx F, Kartheuser A, et al (2014). PROCARE. Effect of hospital volume on quality of care and outcome after rectal cancer surgery. Br J Surg 101:1475–1482.
40.
Zurück zum Zitat Richardson DP, Porter GA, Johnson PM (2013). Surgeon knowledge contributes to the relationship between surgeon volume and patient outcomes in rectal cancer. Ann Surg 257:295–301.CrossRef Richardson DP, Porter GA, Johnson PM (2013). Surgeon knowledge contributes to the relationship between surgeon volume and patient outcomes in rectal cancer. Ann Surg 257:295–301.CrossRef
Metadaten
Titel
A Comparison of Pathologic Outcomes of Open, Laparoscopic, and Robotic Resections for Rectal Cancer Using the ACS-NSQIP Proctectomy-Targeted Database: a Propensity Score Analysis
verfasst von
Richard Garfinkle
Maria Abou-Khalil
Sahir Bhatnagar
Nathalie Wong-Chong
Laurent Azoulay
Nancy Morin
Carol-Ann Vasilevsky
Marylise Boutros
Publikationsdatum
27.09.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 2/2019
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3974-8

Weitere Artikel der Ausgabe 2/2019

Journal of Gastrointestinal Surgery 2/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.